Does OLAPARIB Cause Cytopenia? 44 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Cytopenia have been filed in association with OLAPARIB (Lynparza). This represents 0.2% of all adverse event reports for OLAPARIB.
44
Reports of Cytopenia with OLAPARIB
0.2%
of all OLAPARIB reports
4
Deaths
9
Hospitalizations
How Dangerous Is Cytopenia From OLAPARIB?
Of the 44 reports, 4 (9.1%) resulted in death, 9 (20.5%) required hospitalization, and 3 (6.8%) were considered life-threatening.
Is Cytopenia Listed in the Official Label?
Yes, Cytopenia is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Cytopenia?
RITUXIMAB (1,372)
LENALIDOMIDE (1,252)
DEXAMETHASONE (1,193)
CYCLOPHOSPHAMIDE (1,191)
VENETOCLAX (1,019)
METHOTREXATE (955)
ETOPOSIDE (854)
CARBOPLATIN (754)
DOXORUBICIN (709)
VINCRISTINE (648)
Which OLAPARIB Alternatives Have Lower Cytopenia Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL